Çağatay Taşkıran - Gynecology

Author Information

Çagatay Taskiran is an esteemed researcher affiliated with the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology at Koc University School of Medicine in Istanbul, Turkey. His work primarily focuses on gynecologic oncology, with significant contributions to the understanding and treatment of various gynecologic cancers.

Research Contributions

Çagatay Taskiran has made substantial contributions to the field of gynecologic oncology. His research covers a diverse range of topics including the diagnostic accuracy of sentinel node biopsy in endometrial cancer, perspectives on minimally invasive surgery during the COVID-19 pandemic, and the long-term oncological safety of laparoscopic surgery in endometrial cancer. He has also been involved in multi-center studies and clinical trials, such as those exploring the efficacy of pembrolizumab in combination with chemoradiotherapy for high-risk cervical cancer and investigating prognostic factors in uterine leiomyosarcoma. His work is widely recognized and cited, reflecting his impact on the field.

Aliases

Çagatay Taskiran is known by several aliases, including:

Çagatay Taşkıran Çağatay Taşkiran Çağatay Taşkıran Cagatay Taskiran C. Taskiran

Publication and Citation Metrics

Metric	Value
Total Citation Count	1824
h-index	26
Total Number of Papers	216

Publications:

Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006)

DOI: 10.1016/j.ygyno.2022.01.009

Year: 2022

Perspectives of Gynecologic Oncologists on Minimally Invasive Surgery During COVID-19 Pandemic: A Turkish Society of Minimally Invasive Gynecologic Oncology (MIJOD) Survey.

DOI: 10.31557/APJCP.2022.23.2.573

Year: 2022

Could the Long-Term Oncological Safety of Laparoscopic Surgery in Low Risk Endometrial Cancer be also valid for the High Intermediate and High-Risk Patients? A Multi-center Turkish Gynecologic Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-End-001)

DOI: 10.21203/rs.3.rs-263938/v1

Year: 2021

Perspectives of Gynecologic Oncologists on Minimally Invasive Surgery During COVID-19 Pandemic: A Turkish Society of Minimally Invasive Gynecologic Oncology (MIJOD) Survey

DOI: 10.21203/RS.3.RS-491643/V1

Year: 2021

EPV036/#142 European network for gynaecological oncological trial (ENGOT)-CX11/gynecologic oncology group (GOG) 3047/keynote-A18: phase 3 trial of pembrolizumab plus chemoradiotherapy in high-risk locally advanced cervical cancer

DOI: 10.1136/ijgc-2021-igcs.104

Year: 2021

Association of BRCA1/2, homologous recombination deficiency, and PD-L1 with clinical outcomes in patients receiving atezolizumab versus placebo combined with carboplatin, paclitaxel, and bevacizumab for newly diagnosed ovarian cancer: exploratory analyses of IMagyn050/GOG3015/ENGOT-ov39

DOI: 10.1016/s0090-8258(21)00716-2

Year: 2021

Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-003.

DOI: 10.1016/j.currproblcancer.2021.100712

Year: 2021

261 ENGOT-cx11/GOG 3047/KEYNOTE-A18: phase 3 randomized study of pembrolizumab + chemoradiotherapy for high-risk locally advanced cervical cancer

DOI: 10.1136/ijgc-2021-esgo.21

Year: 2021

931 Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-003

DOI: 10.1136/ijgc-2021-esgo.212

Year: 2021

The principles of safe and efficacious upper abdominal surgery

DOI: 10.21037/GPM-21-3

Year: 2021

What is Ascites?

How does CAH affect female reproductive health?

What are Normal Estrogen Levels?

Who is a Good Candidate?

Are There Alternatives to Opioid Analgesics?

What Do Thyroid Function Test Results Mean?

Why Does Ovulation Bleeding Occur?

What Pain Management Options are Available?

How Common is Sleep Apnea in Women?

What Factors Can Affect INR Levels?

Partnered Content Networks

Relevant Topics